Kathryn Horwitz
Concepts (513)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, Progesterone | 108 | 2020 | 319 | 10.750 |
Why?
| Breast Neoplasms | 116 | 2021 | 1865 | 6.900 |
Why?
| Progesterone | 46 | 2021 | 232 | 5.390 |
Why?
| Receptors, Estrogen | 55 | 2014 | 372 | 4.130 |
Why?
| Progestins | 23 | 2021 | 75 | 2.870 |
Why?
| Estrogens | 17 | 2014 | 313 | 2.100 |
Why?
| Gene Expression Regulation, Neoplastic | 21 | 2015 | 1144 | 2.030 |
Why?
| Tamoxifen | 26 | 2012 | 192 | 1.780 |
Why?
| Transcription, Genetic | 29 | 2012 | 1317 | 1.770 |
Why?
| Estradiol | 28 | 2014 | 455 | 1.730 |
Why?
| SUMO-1 Protein | 4 | 2012 | 19 | 1.000 |
Why?
| Tumor Cells, Cultured | 31 | 2009 | 851 | 0.810 |
Why?
| Gene Expression Profiling | 13 | 2014 | 1523 | 0.800 |
Why?
| Keratin-5 | 4 | 2014 | 46 | 0.760 |
Why?
| Neoplasms, Hormone-Dependent | 8 | 2010 | 38 | 0.730 |
Why?
| Promegestone | 24 | 2005 | 33 | 0.700 |
Why?
| Transcription Factors | 12 | 2009 | 1531 | 0.690 |
Why?
| Gene Expression Regulation | 10 | 2011 | 2329 | 0.670 |
Why?
| Biomarkers, Tumor | 8 | 2020 | 1045 | 0.660 |
Why?
| Cell Proliferation | 9 | 2014 | 2191 | 0.650 |
Why?
| Stromal Cells | 5 | 2014 | 96 | 0.640 |
Why?
| Female | 102 | 2021 | 59617 | 0.620 |
Why?
| Protein Processing, Post-Translational | 4 | 2013 | 399 | 0.610 |
Why?
| Humans | 153 | 2021 | 115047 | 0.600 |
Why?
| HeLa Cells | 15 | 2012 | 562 | 0.590 |
Why?
| Promoter Regions, Genetic | 12 | 2012 | 1133 | 0.590 |
Why?
| Cell Line, Tumor | 19 | 2014 | 2715 | 0.580 |
Why?
| Estrogen Replacement Therapy | 2 | 2008 | 116 | 0.580 |
Why?
| Medroxyprogesterone Acetate | 3 | 2005 | 28 | 0.530 |
Why?
| Cell Nucleus | 26 | 2008 | 556 | 0.510 |
Why?
| Neoplastic Stem Cells | 3 | 2008 | 332 | 0.510 |
Why?
| Animals | 51 | 2014 | 31867 | 0.510 |
Why?
| Mice | 26 | 2014 | 14927 | 0.500 |
Why?
| Antineoplastic Agents, Hormonal | 6 | 2010 | 138 | 0.500 |
Why?
| Neovascularization, Pathologic | 2 | 2014 | 281 | 0.500 |
Why?
| Mifepristone | 11 | 2000 | 60 | 0.490 |
Why?
| Lymphatic Metastasis | 4 | 2010 | 275 | 0.490 |
Why?
| Phosphorylation | 18 | 2013 | 1572 | 0.480 |
Why?
| Platelet-Derived Growth Factor | 2 | 2014 | 82 | 0.480 |
Why?
| Histone Acetyltransferases | 4 | 2012 | 51 | 0.470 |
Why?
| Down-Regulation | 8 | 2009 | 599 | 0.470 |
Why?
| Molecular Sequence Data | 21 | 2009 | 2796 | 0.470 |
Why?
| Epigenomics | 1 | 2015 | 103 | 0.470 |
Why?
| Epidermal Growth Factor | 8 | 2005 | 162 | 0.460 |
Why?
| Transcriptional Activation | 8 | 2009 | 337 | 0.450 |
Why?
| Mice, Nude | 9 | 2012 | 631 | 0.430 |
Why?
| Epithelium | 3 | 2013 | 297 | 0.430 |
Why?
| Protein Isoforms | 6 | 2011 | 339 | 0.410 |
Why?
| Cell Line | 34 | 2009 | 2645 | 0.400 |
Why?
| Cell Division | 12 | 2003 | 758 | 0.400 |
Why?
| DNA-Binding Proteins | 10 | 2000 | 1318 | 0.400 |
Why?
| Binding Sites | 15 | 2006 | 1173 | 0.400 |
Why?
| MCF-7 Cells | 4 | 2020 | 105 | 0.400 |
Why?
| Enzyme Inhibitors | 3 | 2008 | 752 | 0.390 |
Why?
| Repressor Proteins | 5 | 2002 | 368 | 0.390 |
Why?
| Models, Biological | 5 | 2014 | 1636 | 0.390 |
Why?
| Signal Transduction | 17 | 2012 | 4525 | 0.380 |
Why?
| Neoplasm Proteins | 4 | 2005 | 385 | 0.380 |
Why?
| DNA | 11 | 2000 | 1352 | 0.370 |
Why?
| Cyclins | 4 | 1999 | 78 | 0.370 |
Why?
| Receptors, Notch | 1 | 2011 | 85 | 0.370 |
Why?
| Epigenesis, Genetic | 1 | 2015 | 524 | 0.370 |
Why?
| DNA Methylation | 1 | 2015 | 496 | 0.360 |
Why?
| Peritoneal Neoplasms | 1 | 2010 | 53 | 0.350 |
Why?
| Tumor Necrosis Factor Ligand Superfamily Member 15 | 1 | 2010 | 8 | 0.350 |
Why?
| Adenocarcinoma | 2 | 2014 | 795 | 0.350 |
Why?
| Nuclear Proteins | 7 | 2000 | 593 | 0.350 |
Why?
| Transplantation, Heterologous | 6 | 2009 | 182 | 0.340 |
Why?
| Drug Resistance, Neoplasm | 6 | 2010 | 636 | 0.330 |
Why?
| Alu Elements | 1 | 2009 | 26 | 0.330 |
Why?
| Neoplasm Recurrence, Local | 4 | 2013 | 856 | 0.320 |
Why?
| Neoplasm Metastasis | 4 | 2020 | 524 | 0.320 |
Why?
| Milk Proteins | 2 | 1999 | 36 | 0.320 |
Why?
| Neoplasm Transplantation | 4 | 2014 | 230 | 0.310 |
Why?
| Amino Acid Sequence | 12 | 2009 | 1990 | 0.310 |
Why?
| Protein Multimerization | 1 | 2009 | 160 | 0.300 |
Why?
| Aromatase Inhibitors | 1 | 2008 | 49 | 0.300 |
Why?
| Nuclear Receptor Coactivator 1 | 4 | 2012 | 10 | 0.300 |
Why?
| Saccharomyces cerevisiae Proteins | 2 | 2001 | 333 | 0.290 |
Why?
| Cyclic AMP | 5 | 2006 | 226 | 0.290 |
Why?
| Cysteine Endopeptidases | 3 | 2012 | 60 | 0.280 |
Why?
| Cell Fusion | 1 | 2006 | 50 | 0.270 |
Why?
| Ligands | 9 | 2009 | 565 | 0.270 |
Why?
| Breast | 5 | 2001 | 139 | 0.270 |
Why?
| Ovarian Neoplasms | 1 | 2010 | 386 | 0.260 |
Why?
| Selective Estrogen Receptor Modulators | 2 | 2010 | 26 | 0.260 |
Why?
| Models, Theoretical | 2 | 2008 | 517 | 0.260 |
Why?
| Trans-Activators | 5 | 1999 | 368 | 0.250 |
Why?
| Protein Binding | 10 | 2009 | 1898 | 0.250 |
Why?
| Base Sequence | 11 | 2009 | 2119 | 0.240 |
Why?
| Epithelial Cells | 2 | 2010 | 956 | 0.240 |
Why?
| RNA, Messenger | 11 | 2010 | 2563 | 0.240 |
Why?
| DNA, Neoplasm | 6 | 1992 | 157 | 0.240 |
Why?
| Lymph Nodes | 1 | 2006 | 422 | 0.230 |
Why?
| Mutation | 7 | 2012 | 3350 | 0.220 |
Why?
| Gonanes | 5 | 1997 | 27 | 0.220 |
Why?
| Drug Resistance | 8 | 2000 | 158 | 0.220 |
Why?
| Cell Growth Processes | 3 | 2010 | 51 | 0.220 |
Why?
| Disease Models, Animal | 4 | 2014 | 3545 | 0.220 |
Why?
| Estrogen Receptor Modulators | 3 | 2008 | 17 | 0.220 |
Why?
| Sumoylation | 2 | 2013 | 15 | 0.210 |
Why?
| Molecular Weight | 11 | 2000 | 331 | 0.210 |
Why?
| Receptors, Cell Surface | 7 | 1994 | 354 | 0.210 |
Why?
| Peptide Fragments | 5 | 2003 | 668 | 0.210 |
Why?
| Receptors, Steroid | 3 | 1999 | 48 | 0.210 |
Why?
| ErbB Receptors | 4 | 2020 | 555 | 0.210 |
Why?
| Xenograft Model Antitumor Assays | 4 | 2012 | 697 | 0.200 |
Why?
| Phosphoserine | 2 | 2000 | 33 | 0.200 |
Why?
| Antibodies, Monoclonal | 9 | 2006 | 1268 | 0.190 |
Why?
| Norpregnadienes | 3 | 1988 | 7 | 0.190 |
Why?
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1999 | 172 | 0.190 |
Why?
| Immunohistochemistry | 6 | 2008 | 1634 | 0.190 |
Why?
| Leucine Zippers | 3 | 1997 | 16 | 0.190 |
Why?
| Transfection | 8 | 2006 | 872 | 0.190 |
Why?
| Multienzyme Complexes | 2 | 2003 | 64 | 0.180 |
Why?
| Mitogen-Activated Protein Kinases | 2 | 2000 | 278 | 0.180 |
Why?
| Antigens, Nuclear | 1 | 2000 | 19 | 0.180 |
Why?
| Recombinant Fusion Proteins | 6 | 2000 | 616 | 0.180 |
Why?
| Homeodomain Proteins | 3 | 2009 | 464 | 0.180 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2010 | 928 | 0.170 |
Why?
| Poly(ADP-ribose) Polymerases | 1 | 2000 | 88 | 0.170 |
Why?
| Response Elements | 3 | 2009 | 83 | 0.170 |
Why?
| Estrogen Antagonists | 9 | 2000 | 39 | 0.170 |
Why?
| Prolactin | 2 | 1998 | 95 | 0.160 |
Why?
| Kinetics | 15 | 2001 | 1558 | 0.160 |
Why?
| Receptor Cross-Talk | 1 | 1998 | 20 | 0.160 |
Why?
| Amino Acid Motifs | 3 | 2006 | 198 | 0.160 |
Why?
| DNA Helicases | 1 | 2000 | 133 | 0.160 |
Why?
| Disease Susceptibility | 1 | 2021 | 316 | 0.160 |
Why?
| Tumor Suppressor Proteins | 2 | 1998 | 282 | 0.160 |
Why?
| Carcinogenesis | 1 | 2020 | 178 | 0.160 |
Why?
| Hormone Antagonists | 2 | 1997 | 33 | 0.160 |
Why?
| Protein Structure, Tertiary | 3 | 2012 | 798 | 0.150 |
Why?
| Proto-Oncogene Proteins c-fos | 2 | 1998 | 164 | 0.150 |
Why?
| MAP Kinase Signaling System | 1 | 2000 | 276 | 0.150 |
Why?
| Risk | 1 | 2021 | 815 | 0.150 |
Why?
| Progesterone Congeners | 5 | 2008 | 14 | 0.150 |
Why?
| Cyclin-Dependent Kinase Inhibitor p21 | 4 | 1999 | 107 | 0.150 |
Why?
| Affinity Labels | 9 | 1990 | 25 | 0.150 |
Why?
| Mitogen-Activated Protein Kinase Kinases | 2 | 2012 | 114 | 0.150 |
Why?
| Oligonucleotide Array Sequence Analysis | 4 | 2010 | 744 | 0.150 |
Why?
| Oxygenases | 1 | 1997 | 9 | 0.150 |
Why?
| CDC2-CDC28 Kinases | 1 | 1997 | 18 | 0.150 |
Why?
| Mutagenesis, Site-Directed | 5 | 2001 | 345 | 0.150 |
Why?
| Endometrial Neoplasms | 4 | 2008 | 141 | 0.150 |
Why?
| Phosphoproteins | 3 | 2008 | 298 | 0.150 |
Why?
| Nafoxidine | 8 | 1982 | 9 | 0.140 |
Why?
| Endometrium | 2 | 2008 | 60 | 0.140 |
Why?
| Hyaluronan Receptors | 2 | 2008 | 91 | 0.140 |
Why?
| Endopeptidases | 2 | 2012 | 72 | 0.140 |
Why?
| Immunoblotting | 4 | 2004 | 282 | 0.140 |
Why?
| 8-Bromo Cyclic Adenosine Monophosphate | 2 | 1994 | 17 | 0.140 |
Why?
| Carcinogens | 1 | 1997 | 105 | 0.140 |
Why?
| Ribosomal Proteins | 1 | 1997 | 70 | 0.140 |
Why?
| Cytoplasm | 12 | 2006 | 256 | 0.140 |
Why?
| Carcinoma, Endometrioid | 2 | 2008 | 46 | 0.140 |
Why?
| Up-Regulation | 3 | 2009 | 812 | 0.140 |
Why?
| Muscle, Smooth, Vascular | 4 | 2000 | 417 | 0.140 |
Why?
| Cluster Analysis | 4 | 2008 | 458 | 0.140 |
Why?
| Microtubule-Associated Proteins | 1 | 1997 | 174 | 0.130 |
Why?
| Tumor Microenvironment | 2 | 2020 | 431 | 0.130 |
Why?
| Phenotype | 5 | 2011 | 2815 | 0.130 |
Why?
| Blotting, Western | 6 | 2010 | 1149 | 0.130 |
Why?
| Apoptosis | 5 | 2011 | 2366 | 0.130 |
Why?
| Receptors, Glucocorticoid | 7 | 2000 | 131 | 0.130 |
Why?
| Consensus Sequence | 2 | 2009 | 70 | 0.130 |
Why?
| Receptors, Cytoplasmic and Nuclear | 1 | 1996 | 193 | 0.120 |
Why?
| Mammary Neoplasms, Experimental | 7 | 2009 | 64 | 0.120 |
Why?
| Proto-Oncogene Proteins c-jun | 1 | 1994 | 47 | 0.120 |
Why?
| Methylation | 1 | 2015 | 208 | 0.120 |
Why?
| Fibroblasts | 2 | 2020 | 839 | 0.120 |
Why?
| Human Umbilical Vein Endothelial Cells | 1 | 2014 | 89 | 0.110 |
Why?
| Heterografts | 1 | 2014 | 117 | 0.110 |
Why?
| Drug Screening Assays, Antitumor | 1 | 2014 | 180 | 0.110 |
Why?
| Small Molecule Libraries | 1 | 2014 | 80 | 0.110 |
Why?
| Cell Cycle Proteins | 1 | 1997 | 551 | 0.110 |
Why?
| Intracellular Signaling Peptides and Proteins | 2 | 2006 | 386 | 0.110 |
Why?
| Ubiquitination | 1 | 2013 | 86 | 0.110 |
Why?
| Immunophenotyping | 1 | 2014 | 276 | 0.110 |
Why?
| Estrenes | 4 | 1989 | 15 | 0.110 |
Why?
| Immunoenzyme Techniques | 2 | 2010 | 192 | 0.110 |
Why?
| Drug Synergism | 4 | 1998 | 317 | 0.110 |
Why?
| Acetylation | 1 | 2013 | 211 | 0.110 |
Why?
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2012 | 25 | 0.100 |
Why?
| Pregnancy Complications, Neoplastic | 1 | 2013 | 50 | 0.100 |
Why?
| Disease Progression | 3 | 2014 | 2389 | 0.100 |
Why?
| Bone Neoplasms | 1 | 2014 | 194 | 0.100 |
Why?
| Chickens | 6 | 1994 | 177 | 0.100 |
Why?
| Carcinoma, Lobular | 1 | 2012 | 44 | 0.100 |
Why?
| DNA, Complementary | 4 | 2001 | 257 | 0.100 |
Why?
| Claudins | 1 | 2011 | 24 | 0.100 |
Why?
| Cytosol | 9 | 1989 | 208 | 0.100 |
Why?
| Cells, Cultured | 10 | 2006 | 3896 | 0.100 |
Why?
| Bridged-Ring Compounds | 1 | 2011 | 9 | 0.090 |
Why?
| Pyrrolidines | 3 | 1981 | 55 | 0.090 |
Why?
| Amyloid Precursor Protein Secretases | 1 | 2011 | 71 | 0.090 |
Why?
| M Phase Cell Cycle Checkpoints | 1 | 2011 | 23 | 0.090 |
Why?
| Estrogen Receptor alpha | 2 | 2010 | 121 | 0.090 |
Why?
| Nuclear Receptor Co-Repressor 1 | 3 | 2000 | 16 | 0.090 |
Why?
| Genome, Human | 1 | 2013 | 351 | 0.090 |
Why?
| Polyploidy | 1 | 1990 | 16 | 0.090 |
Why?
| Taxoids | 1 | 2011 | 93 | 0.090 |
Why?
| Liver Neoplasms | 1 | 2014 | 516 | 0.090 |
Why?
| Receptor, Insulin | 3 | 1985 | 93 | 0.090 |
Why?
| Acetylcysteine | 2 | 2003 | 142 | 0.090 |
Why?
| COS Cells | 2 | 2003 | 175 | 0.090 |
Why?
| Hormones | 2 | 1993 | 132 | 0.090 |
Why?
| Histones | 1 | 2015 | 535 | 0.090 |
Why?
| Cloning, Molecular | 4 | 2006 | 524 | 0.090 |
Why?
| Antineoplastic Agents | 2 | 2008 | 1879 | 0.090 |
Why?
| Organ Specificity | 1 | 2010 | 270 | 0.090 |
Why?
| Chemokine CXCL12 | 1 | 2010 | 74 | 0.090 |
Why?
| Neoadjuvant Therapy | 2 | 2010 | 298 | 0.080 |
Why?
| Time Factors | 4 | 2008 | 6141 | 0.080 |
Why?
| Epitopes | 1 | 1991 | 436 | 0.080 |
Why?
| Neoplasms, Experimental | 3 | 2008 | 151 | 0.080 |
Why?
| Nuclear Receptor Co-Repressor 2 | 2 | 2000 | 14 | 0.080 |
Why?
| Transcriptome | 1 | 2014 | 725 | 0.080 |
Why?
| Sequence Homology, Nucleic Acid | 1 | 2009 | 152 | 0.080 |
Why?
| Transformation, Genetic | 1 | 1988 | 15 | 0.080 |
Why?
| STAT5 Transcription Factor | 2 | 1999 | 44 | 0.080 |
Why?
| Mitogen-Activated Protein Kinase 3 | 2 | 2000 | 146 | 0.080 |
Why?
| Drug Administration Routes | 1 | 2008 | 40 | 0.080 |
Why?
| Embryonal Carcinoma Stem Cells | 1 | 2008 | 2 | 0.080 |
Why?
| Receptors, Androgen | 4 | 2005 | 131 | 0.080 |
Why?
| MicroRNAs | 1 | 2015 | 603 | 0.080 |
Why?
| Mitogen-Activated Protein Kinase 1 | 2 | 2000 | 164 | 0.080 |
Why?
| Protein Precursors | 1 | 1989 | 119 | 0.080 |
Why?
| Substrate Specificity | 1 | 2009 | 355 | 0.080 |
Why?
| Microdissection | 1 | 2007 | 15 | 0.070 |
Why?
| Mammary Tumor Virus, Mouse | 2 | 2000 | 41 | 0.070 |
Why?
| Dactinomycin | 4 | 1981 | 25 | 0.070 |
Why?
| Androstadienes | 1 | 2008 | 97 | 0.070 |
Why?
| Binding, Competitive | 6 | 1994 | 195 | 0.070 |
Why?
| Pregnanes | 1 | 1986 | 3 | 0.070 |
Why?
| Lasers | 1 | 2007 | 121 | 0.070 |
Why?
| Structure-Activity Relationship | 2 | 2002 | 503 | 0.070 |
Why?
| Neoplasm Invasiveness | 3 | 2020 | 442 | 0.070 |
Why?
| Brain Neoplasms | 1 | 2014 | 984 | 0.070 |
Why?
| Transforming Growth Factor beta | 1 | 2009 | 448 | 0.070 |
Why?
| Protein Biosynthesis | 3 | 2000 | 389 | 0.070 |
Why?
| Pregnanolone | 1 | 1986 | 20 | 0.070 |
Why?
| Recombinant Proteins | 3 | 2003 | 1237 | 0.070 |
Why?
| Receptor, IGF Type 1 | 1 | 2006 | 58 | 0.070 |
Why?
| Drug Administration Schedule | 1 | 2008 | 719 | 0.070 |
Why?
| Pleural Effusion | 1 | 2006 | 47 | 0.070 |
Why?
| Dose-Response Relationship, Drug | 5 | 2005 | 1857 | 0.070 |
Why?
| Cell Cycle | 2 | 1999 | 544 | 0.070 |
Why?
| Menopause | 2 | 2008 | 271 | 0.070 |
Why?
| Mutant Proteins | 1 | 2006 | 95 | 0.070 |
Why?
| Gene Regulatory Networks | 1 | 2007 | 229 | 0.070 |
Why?
| HSP90 Heat-Shock Proteins | 1 | 2006 | 43 | 0.060 |
Why?
| Zinc Fingers | 2 | 1998 | 44 | 0.060 |
Why?
| Chromatography, Affinity | 4 | 1990 | 81 | 0.060 |
Why?
| Methionine | 2 | 2000 | 145 | 0.060 |
Why?
| Uterine Neoplasms | 1 | 2006 | 73 | 0.060 |
Why?
| Regulatory Sequences, Nucleic Acid | 3 | 1997 | 81 | 0.060 |
Why?
| Chromosome Mapping | 4 | 1999 | 490 | 0.060 |
Why?
| Protein Structure, Secondary | 1 | 2006 | 325 | 0.060 |
Why?
| Hydroxyprogesterones | 1 | 1985 | 1 | 0.060 |
Why?
| Keratins | 1 | 2005 | 176 | 0.060 |
Why?
| Thromboplastin | 1 | 2004 | 71 | 0.060 |
Why?
| Dexamethasone | 5 | 2000 | 317 | 0.060 |
Why?
| Cycloheximide | 4 | 1989 | 55 | 0.060 |
Why?
| Biomarkers | 1 | 2014 | 3419 | 0.060 |
Why?
| Protein Conformation | 2 | 2001 | 811 | 0.060 |
Why?
| Chloramphenicol O-Acetyltransferase | 2 | 1994 | 38 | 0.060 |
Why?
| Cell Transformation, Neoplastic | 1 | 2006 | 311 | 0.060 |
Why?
| Dimerization | 2 | 2002 | 176 | 0.060 |
Why?
| Cell Movement | 2 | 2006 | 866 | 0.060 |
Why?
| Patient Care Planning | 1 | 2005 | 139 | 0.060 |
Why?
| Paclitaxel | 1 | 2004 | 190 | 0.060 |
Why?
| Microscopy, Confocal | 1 | 2004 | 305 | 0.060 |
Why?
| Plasmids | 2 | 2002 | 345 | 0.060 |
Why?
| Genes, Reporter | 2 | 1994 | 257 | 0.050 |
Why?
| Proteasome Endopeptidase Complex | 2 | 2003 | 134 | 0.050 |
Why?
| Cell Adhesion | 1 | 2004 | 430 | 0.050 |
Why?
| Biomedical Research | 1 | 2008 | 585 | 0.050 |
Why?
| Analysis of Variance | 1 | 2005 | 1229 | 0.050 |
Why?
| Mutagenesis | 1 | 2003 | 170 | 0.050 |
Why?
| Sequence Alignment | 1 | 2003 | 325 | 0.050 |
Why?
| Sequence Homology, Amino Acid | 1 | 2003 | 353 | 0.050 |
Why?
| Flow Cytometry | 3 | 1992 | 1084 | 0.050 |
Why?
| Oligodeoxyribonucleotides | 2 | 1993 | 138 | 0.050 |
Why?
| Testosterone | 1 | 2005 | 343 | 0.050 |
Why?
| Uterus | 1 | 2003 | 192 | 0.050 |
Why?
| Lung Neoplasms | 1 | 2014 | 2201 | 0.050 |
Why?
| Cell Differentiation | 2 | 2006 | 1700 | 0.050 |
Why?
| Iron Chelating Agents | 1 | 2001 | 16 | 0.050 |
Why?
| Oligonucleotide Probes | 2 | 1992 | 54 | 0.050 |
Why?
| Growth Substances | 2 | 1999 | 137 | 0.050 |
Why?
| Oviducts | 3 | 1986 | 15 | 0.050 |
Why?
| Pregnancy | 1 | 2013 | 5520 | 0.050 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2004 | 499 | 0.050 |
Why?
| Ultracentrifugation | 1 | 2001 | 48 | 0.050 |
Why?
| Gene Library | 2 | 1992 | 114 | 0.050 |
Why?
| Sequence Deletion | 1 | 2001 | 168 | 0.050 |
Why?
| Genetic Variation | 2 | 1999 | 876 | 0.050 |
Why?
| Androgens | 6 | 1986 | 167 | 0.050 |
Why?
| Exons | 2 | 1999 | 301 | 0.050 |
Why?
| CCAAT-Enhancer-Binding Proteins | 1 | 2000 | 34 | 0.040 |
Why?
| DNA-Activated Protein Kinase | 1 | 2000 | 11 | 0.040 |
Why?
| Ku Autoantigen | 1 | 2000 | 13 | 0.040 |
Why?
| Ubiquitins | 1 | 2000 | 31 | 0.040 |
Why?
| CD146 Antigen | 1 | 2020 | 35 | 0.040 |
Why?
| Glutathione Transferase | 1 | 2000 | 95 | 0.040 |
Why?
| Peptides, Cyclic | 1 | 2001 | 254 | 0.040 |
Why?
| Phosphates | 2 | 1993 | 159 | 0.040 |
Why?
| Chromosomes, Human, Pair 17 | 1 | 1999 | 57 | 0.040 |
Why?
| Middle Aged | 5 | 2013 | 26830 | 0.040 |
Why?
| Nucleic Acid Hybridization | 2 | 1990 | 187 | 0.040 |
Why?
| Phosphotyrosine | 1 | 1998 | 33 | 0.040 |
Why?
| Receptors, Growth Factor | 1 | 1998 | 49 | 0.040 |
Why?
| Imidazoles | 1 | 2000 | 209 | 0.040 |
Why?
| Chromosomes, Human, Pair 6 | 1 | 1998 | 44 | 0.040 |
Why?
| STAT1 Transcription Factor | 1 | 1998 | 64 | 0.040 |
Why?
| Protein Folding | 1 | 2000 | 239 | 0.040 |
Why?
| Immunoassay | 2 | 1989 | 95 | 0.040 |
Why?
| Sp1 Transcription Factor | 1 | 1998 | 23 | 0.040 |
Why?
| Hydrocortisone | 3 | 1985 | 267 | 0.040 |
Why?
| JNK Mitogen-Activated Protein Kinases | 1 | 1998 | 144 | 0.040 |
Why?
| Suppression, Genetic | 1 | 1998 | 23 | 0.040 |
Why?
| Glycoproteins | 1 | 2000 | 305 | 0.040 |
Why?
| Cyclin B | 1 | 1997 | 13 | 0.040 |
Why?
| Cyclin A | 1 | 1997 | 15 | 0.040 |
Why?
| Dihydrotestosterone | 3 | 1979 | 39 | 0.040 |
Why?
| p38 Mitogen-Activated Protein Kinases | 1 | 1998 | 262 | 0.040 |
Why?
| Isomerism | 1 | 1997 | 43 | 0.040 |
Why?
| Cell Compartmentation | 3 | 1989 | 52 | 0.040 |
Why?
| Biological Transport | 1 | 1998 | 372 | 0.040 |
Why?
| Cyclin-Dependent Kinase 2 | 1 | 1997 | 32 | 0.040 |
Why?
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 1997 | 58 | 0.040 |
Why?
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 1997 | 69 | 0.040 |
Why?
| G1 Phase | 1 | 1997 | 68 | 0.040 |
Why?
| Zinc Finger E-box-Binding Homeobox 1 | 2 | 2008 | 23 | 0.040 |
Why?
| Blood Platelets | 2 | 1994 | 352 | 0.040 |
Why?
| Yeasts | 1 | 1997 | 49 | 0.040 |
Why?
| Autoantigens | 1 | 2000 | 397 | 0.040 |
Why?
| STAT3 Transcription Factor | 1 | 1998 | 174 | 0.040 |
Why?
| Adult | 5 | 2013 | 30658 | 0.040 |
Why?
| Chromatin | 1 | 2000 | 428 | 0.030 |
Why?
| Cyclin-Dependent Kinases | 1 | 1997 | 111 | 0.030 |
Why?
| Gas Chromatography-Mass Spectrometry | 2 | 1986 | 125 | 0.030 |
Why?
| Pyridines | 1 | 2000 | 426 | 0.030 |
Why?
| Photochemistry | 2 | 1990 | 125 | 0.030 |
Why?
| Gene Expression | 3 | 2006 | 1423 | 0.030 |
Why?
| Centrifugation, Density Gradient | 4 | 1983 | 40 | 0.030 |
Why?
| Membrane Proteins | 1 | 2001 | 1019 | 0.030 |
Why?
| Precipitin Tests | 2 | 2000 | 89 | 0.030 |
Why?
| Risk Factors | 1 | 2008 | 8642 | 0.030 |
Why?
| Rats | 6 | 1991 | 4973 | 0.030 |
Why?
| Prognosis | 3 | 2009 | 3334 | 0.030 |
Why?
| Molecular Structure | 1 | 1996 | 438 | 0.030 |
Why?
| TATA Box | 1 | 1994 | 22 | 0.030 |
Why?
| Biopolymers | 1 | 1994 | 26 | 0.030 |
Why?
| Protein Kinases | 2 | 2008 | 307 | 0.030 |
Why?
| Adenosine Diphosphate | 1 | 1994 | 81 | 0.030 |
Why?
| Chromatography, DEAE-Cellulose | 2 | 1985 | 13 | 0.030 |
Why?
| Genes, jun | 1 | 1993 | 9 | 0.030 |
Why?
| Genes, fos | 1 | 1993 | 33 | 0.030 |
Why?
| Antibodies | 2 | 1986 | 372 | 0.030 |
Why?
| Aneuploidy | 1 | 1994 | 86 | 0.030 |
Why?
| In Vitro Techniques | 1 | 1995 | 1036 | 0.030 |
Why?
| beta-Galactosidase | 1 | 1993 | 62 | 0.030 |
Why?
| Macromolecular Substances | 2 | 1983 | 200 | 0.030 |
Why?
| Karyotyping | 1 | 2012 | 102 | 0.030 |
Why?
| Serotonin | 1 | 1994 | 296 | 0.030 |
Why?
| Reference Values | 1 | 1994 | 748 | 0.030 |
Why?
| Castration | 4 | 1982 | 14 | 0.030 |
Why?
| Ploidies | 1 | 1992 | 17 | 0.030 |
Why?
| Ultraviolet Rays | 2 | 1985 | 368 | 0.020 |
Why?
| 9,10-Dimethyl-1,2-benzanthracene | 2 | 1985 | 22 | 0.020 |
Why?
| Cytokines | 1 | 1999 | 1843 | 0.020 |
Why?
| Clone Cells | 1 | 1992 | 248 | 0.020 |
Why?
| Neoplasms | 1 | 2004 | 2106 | 0.020 |
Why?
| DNA Probes | 1 | 1990 | 59 | 0.020 |
Why?
| Cell Cycle Checkpoints | 1 | 2011 | 84 | 0.020 |
Why?
| Codon | 1 | 1990 | 86 | 0.020 |
Why?
| Peptide Chain Initiation, Translational | 1 | 1990 | 38 | 0.020 |
Why?
| Glucocorticoids | 5 | 2000 | 535 | 0.020 |
Why?
| Rabbits | 1 | 1991 | 750 | 0.020 |
Why?
| Mitosis | 1 | 2011 | 164 | 0.020 |
Why?
| Radioligand Assay | 1 | 1989 | 44 | 0.020 |
Why?
| Acceleration | 1 | 1969 | 29 | 0.020 |
Why?
| Smad3 Protein | 1 | 2009 | 41 | 0.020 |
Why?
| Estrogen Receptor beta | 2 | 2000 | 35 | 0.020 |
Why?
| Formaldehyde | 1 | 1989 | 46 | 0.020 |
Why?
| Cyanogen Bromide | 1 | 1989 | 1 | 0.020 |
Why?
| Estradiol Congeners | 2 | 1981 | 2 | 0.020 |
Why?
| Trypsin | 1 | 1989 | 67 | 0.020 |
Why?
| Peptide Mapping | 1 | 1989 | 60 | 0.020 |
Why?
| Antigen-Antibody Complex | 2 | 1987 | 88 | 0.020 |
Why?
| Mice, SCID | 1 | 2009 | 319 | 0.020 |
Why?
| Microtubules | 1 | 2011 | 237 | 0.020 |
Why?
| Mesoderm | 1 | 2009 | 138 | 0.020 |
Why?
| Endometrial Hyperplasia | 1 | 2008 | 10 | 0.020 |
Why?
| Fluorescent Antibody Technique | 1 | 1989 | 396 | 0.020 |
Why?
| Tissue Array Analysis | 1 | 2008 | 49 | 0.020 |
Why?
| Perilipin-1 | 1 | 2008 | 16 | 0.020 |
Why?
| S100 Proteins | 1 | 2008 | 38 | 0.020 |
Why?
| Phosphorus Radioisotopes | 1 | 1987 | 27 | 0.020 |
Why?
| Mice, Inbred NOD | 1 | 2009 | 559 | 0.020 |
Why?
| Hysterectomy | 1 | 2008 | 106 | 0.020 |
Why?
| Gene Silencing | 1 | 2008 | 172 | 0.020 |
Why?
| Chromatography, High Pressure Liquid | 1 | 1989 | 474 | 0.020 |
Why?
| DNA Primers | 2 | 1998 | 514 | 0.020 |
Why?
| 3-Hydroxysteroid Dehydrogenases | 1 | 1986 | 9 | 0.020 |
Why?
| RNA | 2 | 2005 | 810 | 0.020 |
Why?
| Steroid Hydroxylases | 1 | 1986 | 19 | 0.020 |
Why?
| Protein C Inhibitor | 1 | 2006 | 1 | 0.020 |
Why?
| Cadherins | 1 | 2008 | 175 | 0.020 |
Why?
| Chromatography, Thin Layer | 1 | 1986 | 24 | 0.020 |
Why?
| Chromatography, Gas | 1 | 1986 | 27 | 0.020 |
Why?
| Ligases | 1 | 2006 | 30 | 0.020 |
Why?
| Insulin Receptor Substrate Proteins | 1 | 2006 | 56 | 0.020 |
Why?
| Half-Life | 1 | 1986 | 143 | 0.020 |
Why?
| Stress, Physiological | 1 | 1969 | 377 | 0.020 |
Why?
| Tacrolimus Binding Proteins | 1 | 2006 | 16 | 0.020 |
Why?
| Heterotrimeric GTP-Binding Proteins | 1 | 2006 | 15 | 0.020 |
Why?
| Adaptor Proteins, Vesicular Transport | 1 | 2006 | 45 | 0.020 |
Why?
| Androstenes | 1 | 2005 | 11 | 0.020 |
Why?
| Aged | 3 | 2012 | 19122 | 0.020 |
Why?
| Polymerase Chain Reaction | 2 | 1998 | 999 | 0.020 |
Why?
| Polymers | 1 | 1989 | 447 | 0.020 |
Why?
| Levonorgestrel | 1 | 2005 | 31 | 0.020 |
Why?
| Desogestrel | 1 | 2005 | 40 | 0.020 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 1986 | 317 | 0.020 |
Why?
| 17-alpha-Hydroxyprogesterone | 1 | 1985 | 3 | 0.020 |
Why?
| Amino Acids | 1 | 1988 | 451 | 0.020 |
Why?
| Cell Fractionation | 2 | 1982 | 51 | 0.020 |
Why?
| Cricetinae | 2 | 1999 | 259 | 0.020 |
Why?
| Alkaline Phosphatase | 1 | 2005 | 143 | 0.020 |
Why?
| Molecular Chaperones | 1 | 2006 | 157 | 0.020 |
Why?
| RNA Interference | 1 | 2006 | 437 | 0.020 |
Why?
| Neoplasm Staging | 1 | 2008 | 1169 | 0.010 |
Why?
| Polyethylene Glycols | 1 | 1989 | 561 | 0.010 |
Why?
| Calcitriol | 1 | 1985 | 53 | 0.010 |
Why?
| Sucrose | 1 | 2004 | 91 | 0.010 |
Why?
| Insulin-Like Growth Factor I | 1 | 2006 | 286 | 0.010 |
Why?
| Magnetic Resonance Spectroscopy | 1 | 1986 | 482 | 0.010 |
Why?
| Genes, Dominant | 1 | 2004 | 94 | 0.010 |
Why?
| Homeostasis | 1 | 1988 | 578 | 0.010 |
Why?
| Receptors, Adrenergic, beta | 1 | 1985 | 133 | 0.010 |
Why?
| Carrier Proteins | 1 | 2008 | 696 | 0.010 |
Why?
| NIH 3T3 Cells | 1 | 2004 | 137 | 0.010 |
Why?
| Chromatography, Gel | 1 | 1983 | 125 | 0.010 |
Why?
| Lymphocytes | 1 | 1985 | 334 | 0.010 |
Why?
| Butadienes | 1 | 2003 | 31 | 0.010 |
Why?
| Cysteine Proteinase Inhibitors | 1 | 2003 | 45 | 0.010 |
Why?
| Active Transport, Cell Nucleus | 1 | 2003 | 110 | 0.010 |
Why?
| Disease-Free Survival | 1 | 2004 | 617 | 0.010 |
Why?
| Fatty Acids, Unsaturated | 1 | 2003 | 85 | 0.010 |
Why?
| Serine | 1 | 2003 | 126 | 0.010 |
Why?
| Nitriles | 1 | 2003 | 152 | 0.010 |
Why?
| Bromodeoxyuridine | 1 | 1982 | 72 | 0.010 |
Why?
| Hypophysectomy | 3 | 1977 | 15 | 0.010 |
Why?
| Lipid Metabolism | 1 | 1985 | 449 | 0.010 |
Why?
| RNA, Small Interfering | 1 | 2004 | 541 | 0.010 |
Why?
| Butyrates | 1 | 1982 | 53 | 0.010 |
Why?
| Cell Survival | 1 | 2004 | 1022 | 0.010 |
Why?
| Dogs | 1 | 1982 | 340 | 0.010 |
Why?
| Proportional Hazards Models | 1 | 2004 | 1080 | 0.010 |
Why?
| Deoxyadenosines | 1 | 1980 | 7 | 0.010 |
Why?
| NFI Transcription Factors | 1 | 2000 | 5 | 0.010 |
Why?
| Y-Box-Binding Protein 1 | 1 | 2000 | 4 | 0.010 |
Why?
| Clinical Trials as Topic | 1 | 1984 | 937 | 0.010 |
Why?
| Diethylstilbestrol | 2 | 1979 | 8 | 0.010 |
Why?
| Culture Techniques | 1 | 1999 | 80 | 0.010 |
Why?
| Testosterone Congeners | 1 | 1979 | 7 | 0.010 |
Why?
| Aorta | 1 | 1982 | 389 | 0.010 |
Why?
| Insulin | 1 | 1988 | 2082 | 0.010 |
Why?
| Coumestrol | 1 | 1978 | 1 | 0.010 |
Why?
| Mycotoxins | 1 | 1978 | 3 | 0.010 |
Why?
| Isoflavones | 1 | 1978 | 16 | 0.010 |
Why?
| Coumarins | 1 | 1978 | 20 | 0.010 |
Why?
| Premenopause | 1 | 1999 | 107 | 0.010 |
Why?
| Flavonoids | 1 | 1978 | 68 | 0.010 |
Why?
| Subcellular Fractions | 1 | 1978 | 78 | 0.010 |
Why?
| Gene Deletion | 1 | 1999 | 356 | 0.010 |
Why?
| In Situ Hybridization, Fluorescence | 1 | 1998 | 310 | 0.010 |
Why?
| Regression Analysis | 1 | 2000 | 948 | 0.010 |
Why?
| Remission, Spontaneous | 1 | 1977 | 37 | 0.010 |
Why?
| Postmenopause | 1 | 1999 | 304 | 0.010 |
Why?
| Aged, 80 and over | 1 | 2008 | 6357 | 0.010 |
Why?
| Adrenal Glands | 1 | 1977 | 67 | 0.010 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1984 | 1353 | 0.010 |
Why?
| Hypersensitivity | 1 | 2000 | 256 | 0.010 |
Why?
| Sex Factors | 1 | 1982 | 1721 | 0.010 |
Why?
| Mice, Inbred C57BL | 1 | 2006 | 4718 | 0.010 |
Why?
| Fluoxymesterone | 1 | 1975 | 2 | 0.010 |
Why?
| Ovary | 1 | 1977 | 191 | 0.010 |
Why?
| Recurrence | 1 | 1977 | 941 | 0.010 |
Why?
| Nucleic Acid Conformation | 1 | 1997 | 669 | 0.010 |
Why?
| Cattle | 1 | 1994 | 924 | 0.010 |
Why?
| Treatment Outcome | 1 | 2004 | 9123 | 0.010 |
Why?
| Clostridium tetani | 1 | 1969 | 1 | 0.010 |
Why?
| Nystagmus, Pathologic | 1 | 1969 | 7 | 0.010 |
Why?
| Peptides | 1 | 1994 | 849 | 0.010 |
Why?
| Genetic Vectors | 1 | 1990 | 291 | 0.010 |
Why?
| Corticosterone | 1 | 1969 | 211 | 0.000 |
Why?
| Male | 3 | 1999 | 55735 | 0.000 |
Why?
| Salmonella typhimurium | 1 | 1969 | 158 | 0.000 |
Why?
| Hybridomas | 1 | 1987 | 230 | 0.000 |
Why?
| Adrenalectomy | 2 | 1977 | 60 | 0.000 |
Why?
| Pindolol | 1 | 1985 | 16 | 0.000 |
Why?
| Mice, Inbred BALB C | 1 | 1987 | 1153 | 0.000 |
Why?
| Blood Proteins | 1 | 1985 | 233 | 0.000 |
Why?
| Solubility | 1 | 1980 | 224 | 0.000 |
Why?
| Zeranol | 1 | 1978 | 1 | 0.000 |
Why?
| Zearalenone | 1 | 1978 | 2 | 0.000 |
Why?
| Sex Hormone-Binding Globulin | 1 | 1978 | 48 | 0.000 |
Why?
| Aminoglutethimide | 1 | 1977 | 6 | 0.000 |
Why?
| Species Specificity | 1 | 1976 | 548 | 0.000 |
Why?
|
|
Horwitz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts ![Expand Description](https://profiles.ucdenver.edu/Framework/Images/info.png) Derived automatically from this person's publications. _
Co-Authors ![Expand Description](https://profiles.ucdenver.edu/Framework/Images/info.png) People in Profiles who have published with this person. _
Similar People ![Expand Description](https://profiles.ucdenver.edu/Framework/Images/info.png) People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors ![Expand Description](https://profiles.ucdenver.edu/Framework/Images/info.png) People whose addresses are nearby this person. _
|